200 related articles for article (PubMed ID: 21346249)
21. Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity.
Schena F; Volpi S; Faliti CE; Penco F; Santi S; Proietti M; Schenk U; Damonte G; Salis A; Bellotti M; Fais F; Tenca C; Gattorno M; Eibel H; Rizzi M; Warnatz K; Idzko M; Ayata CK; Rakhmanov M; Galli T; Martini A; Canossa M; Grassi F; Traggiai E
Cell Rep; 2013 Jun; 3(6):1824-31. PubMed ID: 23770243
[TBL] [Abstract][Full Text] [Related]
22. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.
Jin D; Fan J; Wang L; Thompson LF; Liu A; Daniel BJ; Shin T; Curiel TJ; Zhang B
Cancer Res; 2010 Mar; 70(6):2245-55. PubMed ID: 20179192
[TBL] [Abstract][Full Text] [Related]
23. Production of Extracellular Adenosine by CD73
Silva-Vilches C; Ring S; Schrader J; Clausen BE; Probst HC; Melchior F; Schild H; Enk A; Mahnke K
J Invest Dermatol; 2019 Mar; 139(3):541-551. PubMed ID: 30393085
[TBL] [Abstract][Full Text] [Related]
24. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia.
Synnestvedt K; Furuta GT; Comerford KM; Louis N; Karhausen J; Eltzschig HK; Hansen KR; Thompson LF; Colgan SP
J Clin Invest; 2002 Oct; 110(7):993-1002. PubMed ID: 12370277
[TBL] [Abstract][Full Text] [Related]
25. Postnatal Deletion of Podoplanin in Lymphatic Endothelium Results in Blood Filling of the Lymphatic System and Impairs Dendritic Cell Migration to Lymph Nodes.
Bianchi R; Russo E; Bachmann SB; Proulx ST; Sesartic M; Smaadahl N; Watson SP; Buckley CD; Halin C; Detmar M
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):108-117. PubMed ID: 27810998
[TBL] [Abstract][Full Text] [Related]
26. Ecto-enzyme and signaling functions of lymphocyte CD73.
Resta R; Yamashita Y; Thompson LF
Immunol Rev; 1998 Feb; 161():95-109. PubMed ID: 9553767
[TBL] [Abstract][Full Text] [Related]
27. CD73 expression and fyn-dependent signaling on murine lymphocytes.
Yamashita Y; Hooker SW; Jiang H; Laurent AB; Resta R; Khare K; Coe A; Kincade PW; Thompson LF
Eur J Immunol; 1998 Oct; 28(10):2981-90. PubMed ID: 9808167
[TBL] [Abstract][Full Text] [Related]
28. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice.
Montesinos MC; Takedachi M; Thompson LF; Wilder TF; Fernández P; Cronstein BN
Arthritis Rheum; 2007 May; 56(5):1440-5. PubMed ID: 17469101
[TBL] [Abstract][Full Text] [Related]
29. Leucocyte Trafficking via the Lymphatic Vasculature- Mechanisms and Consequences.
Jackson DG
Front Immunol; 2019; 10():471. PubMed ID: 30923528
[TBL] [Abstract][Full Text] [Related]
30. Structure and Immune Function of Afferent Lymphatics and Their Mechanistic Contribution to Dendritic Cell and T Cell Trafficking.
Arasa J; Collado-Diaz V; Halin C
Cells; 2021 May; 10(5):. PubMed ID: 34065513
[TBL] [Abstract][Full Text] [Related]
31. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.
Yegutkin GG; Marttila-Ichihara F; Karikoski M; Niemelä J; Laurila JP; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2011 May; 41(5):1231-41. PubMed ID: 21469131
[TBL] [Abstract][Full Text] [Related]
32. The role of ecto-5'-nucleotidase in endothelial dysfunction and vascular pathologies.
Zukowska P; Kutryb-Zajac B; Toczek M; Smolenski RT; Slominska EM
Pharmacol Rep; 2015 Aug; 67(4):675-81. PubMed ID: 26321267
[TBL] [Abstract][Full Text] [Related]
33. CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism.
Airas L; Niemelä J; Jalkanen S
J Immunol; 2000 Nov; 165(10):5411-7. PubMed ID: 11067892
[TBL] [Abstract][Full Text] [Related]
34. Gene-expression profiling of different arms of lymphatic vasculature identifies candidates for manipulation of cell traffic.
Iftakhar-E-Khuda I; Fair-Mäkelä R; Kukkonen-Macchi A; Elima K; Karikoski M; Rantakari P; Miyasaka M; Salmi M; Jalkanen S
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10643-8. PubMed ID: 27601677
[TBL] [Abstract][Full Text] [Related]
35. Targeting the adenosine pathway for cancer immunotherapy.
Hammami A; Allard D; Allard B; Stagg J
Semin Immunol; 2019 Apr; 42():101304. PubMed ID: 31604539
[TBL] [Abstract][Full Text] [Related]
36. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.
Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H
PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099
[TBL] [Abstract][Full Text] [Related]
37. Imaging leukocyte migration through afferent lymphatics.
Collado-Diaz V; Medina-Sanchez JD; Gkountidi AO; Halin C
Immunol Rev; 2022 Mar; 306(1):43-57. PubMed ID: 34708414
[TBL] [Abstract][Full Text] [Related]
38. Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium.
Kaniewska-Bednarczuk E; Mielcarek M; Chester AH; Slominska EM; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):713-719. PubMed ID: 27906627
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of aging mice to listeriosis: Role of anti-inflammatory responses with enhanced Treg-cell expression of CD39/CD73 and Th-17 cells.
Alam MS; Cavanaugh C; Pereira M; Babu U; Williams K
Int J Med Microbiol; 2020 Feb; 310(2):151397. PubMed ID: 31974050
[TBL] [Abstract][Full Text] [Related]
40. CD39 and CD73 in immunity and inflammation.
Antonioli L; Pacher P; Vizi ES; Haskó G
Trends Mol Med; 2013 Jun; 19(6):355-67. PubMed ID: 23601906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
